Uniphar PLC - Dublin-based healthcare services company - Says it performed in line with expectations in 2023 for gross profit as well as earnings before interest, tax, depreciation and amortisation. Achieves organic gross profit growth in excess of 5%, it says. Gross profit in 2022 was €306.7 million, while Ebitda was €98.0 million. Continues to maintain a strong liquidity position, with lower than projected net debt at the end of the year. Looking ahead, says it is ‘well positioned’ to deliver organic gross profit growth across all divisions. Adds that mergers & acquisitions will continue to play an important role in its growth strategy.
Chief Executive Officer Ger Rabette says: ‘Today’s trading update reflects a strong performance by the group in 2023. Following early delivery on our IPO targets, we have created a new divisional structure to capitalise on our attractive growth opportunities and are now focused on reaching our ambitious new target of [€200 million] Ebitda over the medium-term.’
Uniphar is set to publish its full-year results for 2023 on February 27.
Current stock price: 225.00 pence, up 0.9%
12-month change: down 25%
Copyright 2024 Alliance News Ltd. All Rights Reserved.
